ClinicalTrials.govpublic full text
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
anaplastic large cell lymphoma, alk-positive
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 160347
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.